Chembio Diagnostics Reports Third Quarter 2020 Financial Results
November 05, 2020 16:05 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial...
Chembio Diagnostics to Report Third Quarter 2020 Financial Results on November 5, 2020
October 23, 2020 08:00 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Oct. 23, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
Chembio Diagnostics Submits EUA Application for DPP SARS-CoV-2 Antigen Test System
October 15, 2020 17:55 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the submission...
Chembio Diagnostics Receives FDA Approval for DPP HIV-Syphilis System
October 02, 2020 07:26 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Oct. 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced that the U.S....
Chembio Submits EUA Application for New DPP SARS-CoV-2 IgM/IgG Test System
September 08, 2020 18:00 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced its...
Chembio Diagnostics Reports Second Quarter 2020 Financial Results
August 06, 2020 16:05 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial...
Chembio Diagnostics to Report Second Quarter 2020 Financial Results on August 6, 2020
July 23, 2020 16:10 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., July 23, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
Chembio Diagnostics Announces Preliminary Estimates of Second Quarter 2020 Revenues
July 06, 2020 16:22 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., July 06, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading global point-of-care diagnostic company focused on infectious diseases, today announced its...
Chembio Announces Plans to Seek EUA Approval from FDA for Revised DPP COVID-19 IgM/IgG System and New DPP COVID-19 Antigen System
July 06, 2020 16:11 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., July 06, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading global point-of-care diagnostic company focused on infectious diseases, today announced its...
Chembio Diagnostics Awarded BARDA Contract for Development of DPP COVID-19 Point-of-Care Antigen System
July 06, 2020 16:10 ET
|
Chembio Diagnostics, Inc.
HAUPPAUGE, N.Y., July 06, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced it has been...